Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Client Work

WELL Health Technologies Corp. conducted a C$10.5 million bought deal private placement of convertible debentures

Fasken
Reading Time 1 minute read Subscribe
Client

WELL Health Technologies

WELL Health Technologies Corp. conducted a bought deal private placement offering, including the exercise in full of the underwriters’ overallotment option. The offering involved the underwritten private placement of a total of C$10.5-million aggregate principal amount senior unsecured convertible debentures of WELL Health (at a price of $1,000 per convertible debenture).
 
Fasken advised WELL Health with a team led by Mike Stephens (Corporate Finance & Securities), and included Shahrooz Nabavi (Corporate Finance), Shanlee von Vegesack (Corporate Finance & Securities), Gosia Piasecka (Corporate Finance & Securities) and Myriam Gonzalez (Corporate Finance & Securities).

    Subscribe

    Receive email updates from our team

    Subscribe